SCHEMBL25487019

SCHEMBL25487019

CC(C)c1ccc(C(=O)O)cc1OCC#N

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.51
ALOX15 P16050 1/20 0.51
HTT P42858 1/20 0.51
RXRA P19793 8/20 0.48
RXRB P28702 2/20 0.48
RXRG P48443 2/20 0.48
TSHR P16473 1/20 0.46
ACE2 Q9BYF1 2/20 0.45
CYSLTR1 Q9Y271 2/20 0.44
PPARG P37231 1/20 0.43
ALDH1A1 P00352 3/20 0.43
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
KDM4E B2RXH2 1/20 0.43
SRD5A2 P31213 1/20 0.42
HPGD P15428 1/20 0.42
NPBWR1 P48145 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
MCHR1 Q99705 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23793741 0.83 TSHR (0.64) POLBRXRARXRBRXRGTSHR
SCHEMBL23792970 0.82 HTT (0.52) POLBALOX15HTTRXRARXRB
SCHEMBL25484510 0.81 RXRA (0.68) RXRARXRBRXRGTSHRACE2
SCHEMBL2589987 0.79 TSHR (0.68) POLBALOX15HTTTSHRALDH1A1
SCHEMBL25484527 0.78 RXRA (0.50) POLBRXRARXRBRXRGTSHR
SCHEMBL25484516 0.78 RXRA (0.63) RXRARXRBRXRGTSHRALDH1A1
SCHEMBL23793751 0.78 HTT (0.48) POLBALOX15HTTTSHRCYSLTR1
SCHEMBL25484238 0.77 ALDH1A1 (0.50) TSHRALDH1A1MEN1KMT2AL3MBTL1
SCHEMBL25494873 0.77 HTT (0.48) POLBALOX15HTTTSHRCYSLTR1
SCHEMBL13889423 0.77 CA12 (0.65) HTTRXRARXRBRXRGTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230265055-A1 STAT INIHIBITORY COMPOUNDS AND COMPOSITIONS OXFORD FINANCE LLC 2023-08-24 US disclosed
US-20230159445-A1 STAT INHIBITORY COMPOUNDS AND COMPOSITIONS OXFORD FINANCE LLC 2023-05-25 US disclosed
US-20230137956-A1 ALPHA SUBSTITUTED STAT INHIBITORS AND COMPOSITIONS THEREOF OXFORD FINANCE LLC 2023-05-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230159445-A1 STAT INHIBITORY COMPOUNDS AND COMPOSITIONS STAT5A, STAT5B, STAT3 POLB 2843/4885ALOX15 2289/4885HTT 4469/4885
US-20230137956-A1 ALPHA SUBSTITUTED STAT INHIBITORS AND COMPOSITIONS THEREOF STAT5A, STAT5B, STAT3 POLB 2119/4885ALOX15 3537/4885HTT 4470/4885
US-20230265055-A1 STAT INIHIBITORY COMPOUNDS AND COMPOSITIONS STAT5B, STAT5A, STAT3 POLB 2923/4885ALOX15 2864/4885HTT 3920/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.